Sobi gains distribution rights for Megace®, Monopril®, Cefzil® and Duricef® from PharmaSwiss

World News: . []

Stockholm Sweden 13 February 2013 - Sobi STO Sobi announced that it has entered into a distribution agreement with PharmaSwiss to market the products Megace®, Monopril Cefzil and Duricef® approved for the treatment of indications within the on...

More news and information about Swedish Orphan Biovitrum AB (publ)

Published By:

Thomson Reuters: 07:31 GMT Wednesday 13th February 2013

Published: .

Search for other references to "sobi" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us